Iterum Therapeutics Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Corey Fishman
Amministratore delegato
US$1.5m
Compenso totale
| Percentuale dello stipendio del CEO | 40.3% |
| Mandato del CEO | 9yrs |
| Proprietà del CEO | 0.5% |
| Durata media del management | 3.9yrs |
| Durata media del Consiglio di amministrazione | 8.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
Aug 19
Iterum Therapeutics Non-GAAP EPS of -$0.03 beats by $0.03
Aug 12Iterum jumps 64% as FDA agrees to Phase 3 trial for UTI candidate
Jul 11Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
May 06Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
Jan 12Is Iterum Therapeutics (NASDAQ:ITRM) A Risky Investment?
Sep 25Despite Risks Around Regulatory Approval, Iterum Therapeutics Rates A Speculative Buy
Jul 05It's Unlikely That The CEO Of Iterum Therapeutics plc (NASDAQ:ITRM) Will See A Huge Pay Rise This Year
Jun 11Is Iterum Therapeutics (NASDAQ:ITRM) Using Debt Sensibly?
May 20Have Insiders Been Selling Iterum Therapeutics plc (NASDAQ:ITRM) Shares?
Feb 04This Insider Has Just Sold Shares In Iterum Therapeutics plc (NASDAQ:ITRM)
Feb 04Iterum Therapeutics shares slide 13% on raising $10M
Feb 03Iterum Therapeutics rises 39% on RA Capital stake disclosure
Dec 03Iterum Therapeutics files US application for sulopenem in urinary tract infections
Nov 30Iterum Therapeutics EPS beats by $0.45
Nov 16Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$31m |
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$36m |
| Dec 31 2023 | US$2m | US$612k | -US$38m |
| Sep 30 2023 | n/a | n/a | -US$31m |
| Jun 30 2023 | n/a | n/a | -US$56m |
| Mar 31 2023 | n/a | n/a | -US$51m |
| Dec 31 2022 | US$1m | US$589k | -US$44m |
| Sep 30 2022 | n/a | n/a | -US$44m |
| Jun 30 2022 | n/a | n/a | -US$11m |
| Mar 31 2022 | n/a | n/a | US$4m |
| Dec 31 2021 | US$11m | US$573k | -US$92m |
| Sep 30 2021 | n/a | n/a | -US$99m |
| Jun 30 2021 | n/a | n/a | -US$115m |
| Mar 31 2021 | n/a | n/a | -US$135m |
| Dec 31 2020 | US$2m | US$561k | -US$52m |
| Sep 30 2020 | n/a | n/a | -US$64m |
| Jun 30 2020 | n/a | n/a | -US$84m |
| Mar 31 2020 | n/a | n/a | -US$99m |
| Dec 31 2019 | US$1m | US$551k | -US$103m |
| Sep 30 2019 | n/a | n/a | -US$104m |
| Jun 30 2019 | n/a | n/a | -US$97m |
| Mar 31 2019 | n/a | n/a | -US$85m |
| Dec 31 2018 | US$2m | US$495k | -US$77m |
| Sep 30 2018 | n/a | n/a | -US$62m |
| Jun 30 2018 | n/a | n/a | -US$45m |
| Mar 31 2018 | n/a | n/a | -US$36m |
| Dec 31 2017 | US$755k | US$420k | -US$29m |
Compensazione vs Mercato: La retribuzione totale di Corey ($USD 1.52M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 646.00K ).
Compensazione vs guadagni: La retribuzione di Corey è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Corey Fishman (59 yo)
9yrs
Mandato
US$1,518,811
Compensazione
Mr. Corey N. Fishman serves as Independent Director at BioSpecifics Technologies Corp. since April 9, 2020. Mr. Fishman has been President, Chief Executive Officer and Director at Iterum Therapeutics plc (...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 9yrs | US$1.52m | 0.50% $ 281.0k | |
| Chief Financial Officer | 9yrs | US$827.77k | 0.030% $ 16.7k | |
| Strategic Advisor & Director | 3.9yrs | US$115.00k | 0.80% $ 451.0k | |
| Senior Vice President of Technical Operations | 3.8yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Legal Affairs & Secretary | 3.8yrs | Nessun dato | Nessun dato | |
| Senior VP & Head of Clinical Development | no data | Nessun dato | Nessun dato |
3.9yrs
Durata media
59yo
Età media
Gestione esperta: Il team dirigenziale di ITRM è considerato esperto (durata media dell'incarico 3.9 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 9yrs | US$1.52m | 0.50% $ 281.0k | |
| Strategic Advisor & Director | 3.9yrs | US$115.00k | 0.80% $ 451.0k | |
| Independent Chairman of the Board | 9yrs | US$88.75k | 0.052% $ 29.4k | |
| Independent Director | 3.7yrs | US$68.50k | 0.068% $ 38.6k | |
| Independent Director | 8.3yrs | US$74.00k | 0.0090% $ 5.1k |
8.3yrs
Durata media
60yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ITRM sono considerati esperti (durata media dell'incarico 8.3 anni).